Investing.com - Gilead (NASDAQ:GILD) reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Gilead announced earnings per share of $2.11 on revenue of $6.58B. Analysts polled by Investing.com anticipated EPS of $1.92 on revenue of $6.34B.
Gilead shares are down 9% from the beginning of the year and are trading at $58.73 , down-from-52-week-high.They are under-performing the Nasdaq which is up 22.65% from the start of the year.
Gilead follows other major Healthcare sector earnings this month
Gilead's report follows an earnings beat by J&J on Tuesday, October 13, 2020, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on Tuesday with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.69 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar